Event: 8th Annual Clinical Trials 2017

Date: May 24, 2017

Venue: Kohinoor Continental Hotel, Mumbai, India

Weblink: www.virtueinsight.com/pharma/8th-Annual-Clinical-Trials-Summit-2017

Contact: T. Kavitha

Tel: + 91 44 64998743

Email: Kavitha@virtueinsight.co.in

Virtue Insight’s 8th Annual Clinical Trials Summit will bring together leaders from across pharma, biotech and academia to share case studies and best practices on effective clinical trial management and vendor oversight. The 2017 program focuses on key issues and opportunities in the clinical trial industry, including Patient Recruitment, Site Selection, Data Integration, Existing Data Sources, Mobile Tech, Project Management, Outsourcing, Vendor Management, Risk-Based Monitoring, Clinical Auditing, Regulatory Authorities, pharmaceutical industries, contract research organizations, patient associations, and academic groups are represented. This conference is known to facilitate the interaction between all stakeholders, speakers and participants, thus encouraging lively Q&A sessions without cultural barriers. In addition, as usual, this Conference represents a great opportunity to network with all players involved in drug and device development.

Virtue Insight also offers comprehensive sponsorship packages, which includes presentation opportunities, exhibit space, branding and networking with specific prospects.

KEY THEMES DISCUSSED:-

• Develop faster, more effective strategies by setting up big data with the power of sophisticated analytics
• Outsourcing early stage manufacturing
• Benefits and challenges with using local and international vendors
• Develop trial design and elaborate patient access
• Span all phases of clinical and observational research
• How we use mobile in clinical trials nowadays? What is the present barrier?
• Integrated approaches to using digital as a clinical Tool: Real world trials and population health in the east India
• DATA – Collection, Design, Storage, Execute and Manage clinical trials - an architect’s perspective
• Updates on development for safety reporting in Indian clinical trial regulation
• Be part of a major networking opportunity